Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy
Document Type
Article
Publication Date
10-20-2021
Publication Title
TIL Therapies Summit
Keywords
oregon; portland; chiles
Clinical Institute
Cancer
Department
Earle A. Chiles Research Institute
Department
Oncology
Recommended Citation
Weinberg, Andrew D., "Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy" (2021). Articles, Abstracts, and Reports. 5625.
https://digitalcommons.providence.org/publications/5625
